Skip to main content
AQST logo
AQST
(NASDAQ)
Aquestive Therapeutics, Inc.
$5.08-- (--)
Loading... - Market loading

Aquestive Therapeutics (AQST) Stock Price & Financial Analysis

Aquestive Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.72 - $5.12
52-Week High$7.55
52-Week Low$2.93
Open$4.77
Volume3.66M
Average Volume (3M)3.18M
Market Cap622.86M
Shares Outstanding122.61M
Price to Sales (P/S)12.39
Price to Book (P/B)-18.29
EV/EBITDA-10.70
Revenue (TTM)50.27M
Net Income (TTM)-68.91M
Free Cash Flow (TTM)-44.32M
EPS (TTM)$-0.61
Profit Margin-137.08%
Operating Margin-111.18%
50-Day MA$4.20
200-Day MA$4.48
52-Week Change31.61%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Aquestive Therapeutics

What is the current stock price for AQST?

As of the latest trading session, AQST stock trades at $5.08. The 52-week range is $2.93–$7.55, with a day range of $4.72–$5.12.

What is the P/E ratio for AQST?

The P/E ratio (Price-to-Earnings) for AQST is shown in the Key Statistics section. This valuation metric helps compare Aquestive Therapeutics, Inc. to industry peers.

Does AQST pay dividends?

Aquestive Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AQST?

Based on 4 analysts, the consensus for AQST is Buy.

What is the market cap of AQST?

Aquestive Therapeutics's market capitalization is $622.9M, classifying it as a small-cap company. Aquestive Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.